Zobrazeno 1 - 10
of 207
pro vyhledávání: '"E, Stergiou"'
Publikováno v:
Immuno, Vol 2, Iss 4, Pp 584-608 (2022)
Among other systemic autoimmune diseases, primary Sjögren syndrome (pSS) bears the highest risk for lymphoma development. In pSS, chronic antigenic stimulation gradually drives the evolution from polyclonal B-cell expansion to oligoclonal/monoclonal
Externí odkaz:
https://doaj.org/article/e01afe237a2a45219a0ca2c8220ae43e
Autor:
Ioanna E. Stergiou, Kostas Palamaris, Georgia Levidou, Maria Tzimou, Stavros P. Papadakos, Georgios Mandrakis, Christos Masaoutis, Dimitra Rontogianni, Stamatios Theocharis
Publikováno v:
Biomedicines, Vol 12, Iss 4, p 772 (2024)
Background: Programmed death-ligand 1 (PD-L1) expression in neoplastic and immune cells of the tumor microenvironment determines the efficacy of antitumor immunity, while it can be regulated at the epigenetic level by various factors, including HDACs
Externí odkaz:
https://doaj.org/article/58e78d6db821496780e08237bb3685ce
Autor:
Stavros P. Papadakos, Konstantinos Arvanitakis, Ioanna E. Stergiou, Christos Vallilas, Stavros Sougioultzis, Georgios Germanidis, Stamatios Theocharis
Publikováno v:
Pharmaceutics, Vol 15, Iss 10, p 2460 (2023)
Hepatocellular carcinoma (HCC) stands as a significant contributor to global cancer-related mortality. Chronic inflammation, often arising from diverse sources such as viral hepatitis, alcohol misuse, nonalcoholic fatty liver disease (NAFLD), and non
Externí odkaz:
https://doaj.org/article/c1c0af4022f04690add251f0fe58ffdc
Autor:
Stavros P. Papadakos, Nikolaos Machairas, Ioanna E. Stergiou, Konstantinos Arvanitakis, Georgios Germanidis, Adam Enver Frampton, Stamatios Theocharis
Publikováno v:
Cells, Vol 12, Iss 16, p 2036 (2023)
Hepatocellular carcinoma (HCC) is a primary liver cancer with a high mortality rate and limited treatment options. Recent research has brought attention to the significant importance of intercellular communication in the progression of HCC, wherein e
Externí odkaz:
https://doaj.org/article/5faa3228ef7845b78121a631b94c068e
Autor:
Loukas Chatzis, Andreas V. Goules, Ioanna E. Stergiou, Michael Voulgarelis, Athanasios G. Tzioufas, Efstathia K. Kapsogeorgou
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Recent studies suggest that elevated CXCL13 serum levels in patients with primary Sjögren’s syndrome (pSS) associate with minor salivary gland (MSG) histologic features, disease severity, as well as high-risk status for non-Hodgkin lymphoma (NHL)
Externí odkaz:
https://doaj.org/article/af9c629172a9476e98524618ca1e1220
Autor:
Ioanna E, Stergiou, Athanasios-Dimitrios, Bakasis, Stavroula, Giannouli, Michael, Voulgarelis
Publikováno v:
Expert Review of Clinical Immunology. 18:1155-1171
Primary Sjögren's syndrome (pSS) is a chronic autoimmune disease standing in the crossroads of autoimmunity and lymphomagenesis, characterized by chronic B-cell hyperactivity and ectopic lymphoid tissue neoformation, potentially driving lymphoid mal
Publikováno v:
International Journal of Lean Six Sigma. 14:209-251
Purpose The purpose of this paper is the development of a reference model contributing to the identification of the retail supply chain activities that can be improved by the implementation of Lean Six Sigma (LSS) initiatives, following DMAIC steps a
Publikováno v:
International Journal for Research in Applied Science and Engineering Technology. 10:1013-1027
Industry 4.0 is a rapidly evolving concept that has received attention in recent years and aims to achieve a higher and more efficient production rate through automation. Because its implementation involves the improvement of business processes, this
Autor:
Loukas G Chatzis, Ioanna E Stergiou, Andreas V Goules, Vasilis Pezoulas, Gerasimos Tsourouflis, Dimitrios Fotiadis, Athanasios G Tzioufas, Michael Voulgarelis
Publikováno v:
Rheumatology. 61:3576-3585
Objectives Primary Sjögren’s Syndrome (pSS) carries the highest risk for non-Hodgkin's lymphoma (NHL) development among systemic autoimmune diseases. However, the paucity of data on the long-term survival of those patients and the lack of establis
Autor:
Ioanna E. Stergiou, Loukas G. Chatzis, Vasilis C. Pezoulas, Chiara Baldini, Dimitris I. Fotiadis, Michalis Voulgarelis, Athanasios G. Tzioufas, Andreas V. Goules
Publikováno v:
Clinical and experimental rheumatology. 40(12)
Previous cohort studies have shown that around 10% of patients with primary Sjögren's syndrome (pSS) develop lymphadenopathy during their disease course. However, no studies have described their clinical phenotype. The present study aims to describe